1643 — Modern Chinese Medicine Co Share Price
Last trade - 00:00- HK$213.00m
- -HK$31.35m
- CNY214.07m
- 68
- 79
- 45
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.44 | ||
| Price to Tang. Book | 0.44 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1 | ||
| EV to EBITDA | -0.64 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.02% | ||
| Return on Equity | 2.02% | ||
| Operating Margin | 6.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 308.69 | 360.69 | 399.66 | 344.07 | 214.07 | n/a | n/a | -0.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +35.01 | +12.15 | +6.25 | -44.41 | -80.18 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Modern Chinese Medicine Group Co Ltd is a China-based investment holding company that mainly produces Chinese patent medicines. The Company mainly provides over-the-counter (OTC) and prescribed medicine intended for use by the middle-aged and elderly people. The Company's main products are Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxremoving Pill. The Company is also engaged in the production of other traditional Chinese medicines designed to treat or relieve other conditions such as psychological, respiratory, and pediatric conditions. The Company mainly conducts business within the domestic market.
Directors
- Hongli Zhang CEO (56)
- Wen Tao Li CFO (38)
- Jinglian Li COO (41)
- Zhendong Jiang DGD (38)
- Kwan Wai Leung SEC
- Kam Leung Chan NID (46)
- Tsz Wing Leung NID (37)
- Ling Liu NID (60)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 12th, 2019
- Public Since
- January 15th, 2021
- No. of Employees
- 190
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 600,000,000
- Address
- No. 88 Jinwei Road, CHENGDE
- Web
- https://www.cdysjdyy.com/
- Phone
- Auditors
- Mazars CPA Limited
Upcoming Events for 1643
Similar to 1643
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 22:06 UTC, shares in Modern Chinese Medicine Co are trading at HK$0.38. This share price information is delayed by 15 minutes.
Shares in Modern Chinese Medicine Co last closed at HK$0.38 and the price had moved by +24.59% over the past 365 days. In terms of relative price strength the Modern Chinese Medicine Co share price has outperformed the FTSE Developed Asia Pacific Index by +26.01% over the past year.
There is no consensus recommendation for this security.
Find out moreModern Chinese Medicine Co does not currently pay a dividend.
Modern Chinese Medicine Co does not currently pay a dividend.
Modern Chinese Medicine Co does not currently pay a dividend.
To buy shares in Modern Chinese Medicine Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.38, shares in Modern Chinese Medicine Co had a market capitalisation of HK$213.00m.
Here are the trading details for Modern Chinese Medicine Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1643
Based on an overall assessment of its quality, value and momentum Modern Chinese Medicine Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Modern Chinese Medicine Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +18.43%.
As of the last closing price of HK$0.38, shares in Modern Chinese Medicine Co were trading +0.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Modern Chinese Medicine Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Modern Chinese Medicine Co's management team is headed by:
- Hongli Zhang - CEO
- Wen Tao Li - CFO
- Jinglian Li - COO
- Zhendong Jiang - DGD
- Kwan Wai Leung - SEC
- Kam Leung Chan - NID
- Tsz Wing Leung - NID
- Ling Liu - NID